<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Uribe IR</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NICHD NIH HHS</funding><funding>NIH Office of the Director</funding><funding>NIAID NIH HHS</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>National Institute of Child Health and Human Development</funding><funding>NIH HHS</funding><pagination>1791-1803</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12282491</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(4)</volume><pubmed_abstract>ADP-ribosylation, characterized by the addition of adenosine diphosphate ribose, can occur in both monomeric (MARylation) and polymeric (PARylation) forms. Little is known about the specific contributions of MARylation and PARylation to cellular processes due to a lack of tools for jointly investigating these individual forms. We present a novel mass spectrometry (MS)-based proteomics approach that preserves information about the native ADP-ribosylation form associated with the modification site within a single proteomics experiment. Our workflow enables the simplified, binary identification of ADP-ribosylation forms, avoiding some challenges typically presented by PARylated peptides during MS analysis. Our method uses the coronaviral enzyme NS2 to reverse our previous labeling approach, E</pubmed_abstract><journal>Journal of proteome research</journal><pubmed_title>dELTA-MS: A Mass Spectrometry-Based Proteomics Approach for Identifying ADP-Ribosylation Sites and Forms.</pubmed_title><pmcid>PMC12282491</pmcid><funding_grant_id>R01 HD106051</funding_grant_id><funding_grant_id>R01 GM104135</funding_grant_id><funding_grant_id>R35GM147140</funding_grant_id><funding_grant_id>R35 GM147140</funding_grant_id><funding_grant_id>R01AI118891</funding_grant_id><funding_grant_id>R01 AI118891</funding_grant_id><funding_grant_id>R44 GM153000</funding_grant_id><funding_grant_id>R01HD106051</funding_grant_id><funding_grant_id>F31GM143918</funding_grant_id><funding_grant_id>F31 GM143918</funding_grant_id><funding_grant_id>S10 OD021844</funding_grant_id><funding_grant_id>R01GM104135</funding_grant_id><funding_grant_id>S10OD021844</funding_grant_id><funding_grant_id>R44GM153000</funding_grant_id><pubmed_authors>Dasovich M</pubmed_authors><pubmed_authors>Na CH</pubmed_authors><pubmed_authors>Filippov DV</pubmed_authors><pubmed_authors>Hunt SR</pubmed_authors><pubmed_authors>Leung AKL</pubmed_authors><pubmed_authors>Zahn E</pubmed_authors><pubmed_authors>Garcia BA</pubmed_authors><pubmed_authors>Orsburn BC</pubmed_authors><pubmed_authors>Uribe IR</pubmed_authors><pubmed_authors>Onuoha UC</pubmed_authors><pubmed_authors>Searfoss R</pubmed_authors><pubmed_authors>Voorneveld J</pubmed_authors><pubmed_authors>Valadez C</pubmed_authors><pubmed_authors>Kim HB</pubmed_authors></additional><is_claimable>false</is_claimable><name>dELTA-MS: A Mass Spectrometry-Based Proteomics Approach for Identifying ADP-Ribosylation Sites and Forms.</name><description>ADP-ribosylation, characterized by the addition of adenosine diphosphate ribose, can occur in both monomeric (MARylation) and polymeric (PARylation) forms. Little is known about the specific contributions of MARylation and PARylation to cellular processes due to a lack of tools for jointly investigating these individual forms. We present a novel mass spectrometry (MS)-based proteomics approach that preserves information about the native ADP-ribosylation form associated with the modification site within a single proteomics experiment. Our workflow enables the simplified, binary identification of ADP-ribosylation forms, avoiding some challenges typically presented by PARylated peptides during MS analysis. Our method uses the coronaviral enzyme NS2 to reverse our previous labeling approach, E</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-03-27T15:14:37.627Z</modification><creation>2025-08-23T03:09:03.569Z</creation></dates><accession>S-EPMC12282491</accession><cross_references><pubmed>40079415</pubmed><doi>10.1021/acs.jproteome.4c00890</doi></cross_references></HashMap>